Dow Down1.60% Nasdaq Down0.39%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
135.36 Down 3.46(2.49%) 4:00PM EST
|After Hours : 135.36 0.00 (0.00%) 4:45PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 666,637   636,210   600,333   599,476  
Cost of Revenue54,057  52,007  69,399  49,439  
Gross Profit 612,580   584,203   530,934   550,037  
Operating Expenses
Research Development165,664  131,693  221,080  129,110  
Selling General and Administrative212,520  221,383  187,116  183,776  
Non Recurring43,220  50,045  19,031  33,456  
Others36,608   -   -   -  
Total Operating Expenses458,012   -   -   -  
Operating Income or Loss 154,568   181,082   103,707   203,695  
Income from Continuing Operations
Total Other Income/Expenses Net4,762  181  3,889  2,195  
Earnings Before Interest And Taxes159,330  181,263  107,596  205,890  
Interest Expense19,971  3,971  651  549  
Income Before Tax139,359  177,292  106,945  205,341  
Income Tax Expense323,116  7,077  15,622  52,009  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(183,757)170,215  91,323  153,332  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (183,757) 170,215   91,323   153,332  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (183,757) 170,215   91,323   153,332  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.